Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mifepristone Versus Placebo to Treat Adenomyosis: a Double-blind, Multicentre，Randomized Clinical Trial

NCT03520439 is registered in ClinicalTrials.gov with xinmei zhang as lead sponsor.

NCT NCT03520439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mifepristone Versus Placebo to Treat Adenomyosis: a Double-blind, Multicentre，Randomized Clinical Trial
Lead sponsor
xinmei zhang
Phase
Phase 2/3
Overall status
Completed
Start date
May 19, 2018
Completion date
October 1, 2019
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenomyosis